Andrew Fursman

Andrew Fursman is a seasoned executive with extensive experience in technology and healthcare innovation. Currently serving as Chairperson of the Board at Irréversible Inc. since January 2024 and as Chief Executive Officer at 1QB Information Technologies (1QBit) since February 2013, Andrew also founded Synthesis Health, which became an independent entity in January 2023. In addition to roles at Singularity University as Faculty and Satellogic as Co-founder, Andrew has held positions such as Consultant at Fursman Activities Corporation and has advised Replayz. Notably, Andrew co-founded The Good Chemistry Company, which became independent in early 2023 before acquisition in 2024. Educational qualifications include a BA in Economics from the University of Waterloo, a joint BA in Philosophy and Political Science from The University of British Columbia, and a Master's in Financial Engineering from Stanford University, among others.